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Abstract	
Guidelines recommend that clinicians practice shared decision-making (SDM) with women in their 40s
to discuss breast cancer screening. Traditionally, SDM includes discussion of values and preferences
to help determine a decision that is congruent with what the patient desires. We analyzed 54 women’s
breast cancer screening decisions after a SDM conversation with their clinician. We looked at both
patient and clinician characteristics that predicted whether or not a woman would get a screening
mammogram. Women with a family history of breast cancer or who had a previous abnormal
mammogram had higher rates of screening. Screening rates also varied widely between clinicians,
raising the question of whether clinician attitudes impacted the SDM conversation. (J Patient Cent Res
Rev. 2021;8:331-335.)
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B

reast cancer continues to be the most common
new cancer diagnosis in women. Mammography
screening programs have decreased mortality from
breast cancer in women of all ages. The U.S. Preventive
Services Task Force has recommended that clinicians use
shared decision-making (SDM) with women in their 40s
to determine whether their individual risk factors and
values support screening.1 Due to the low prevalence
of breast cancer among women 40–49 years of age and
the high occurrence of false positives, the benefit/harm
ratio for screening mammography in this age group has
prompted calls for risk- and preference-based SDM.
Traditionally, SDM includes discussion of values and
preferences to help determine a decision that is congruent
with what the patient desires.
Clinicians can play an important role in helping women
belonging to this borderline age group make an informed
decision. Previous data have shown variations in
screening practices among primary care clinicians.2,3 Use
of a decision aid improves patient knowledge of risks
and benefits of breast cancer screening but has a variable
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effect on screening rates.4 This study reviewed data from
a breast cancer screening SDM project targeting women
in their 40s and evaluated whether there were patient or
clinician factors that predicted whether or not a woman
would get a screening mammogram.

METHODS

This prospective study took place across 4 different
primary care practices within UW Health (the health
system for the University of Wisconsin-Madison).
Patients and clinicians both were asked to consent to
study participation, which included audiotaping of a
regularly scheduled well-woman exam visit (during May
2017–May 2018). Patients were excluded if they had had
breast cancer or if they had already had a mammogram
within the 12 months prior to the visit. The research team
evaluated patient characteristics using the self-reported
data from a patient survey completed at the visit as part of
the study, collected clinician demographics from publicly
available sources, and assessed subsequent screening
behaviors using data from the electronic health record.
All women had a SDM conversation with the clinician
using an online patient decision aid (www.healthdecision.
org). These conversations were audiotaped, transcribed,
and analyzed for characteristics of SDM.
Groups of patients were further analyzed based on
respective clinician background (eg, identity, years in
practice) to evaluate how clinician characteristics may
shape screening behavior. To meaningfully differentiate
aah.org/jpcrr
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between clinician levels of experience, we grouped
years in practice into 4 ordered categories: <10 years,
10–20 years, 21–30 years, >30 years. We calculated two
alternative measures of screening behavior for clinicians
grouped by years in practice: 1) By averaging the
screening rates for the clinicians within each group, and
2) by combining the patients for clinicians within each
group and calculating the screening rate for the group. We
present results using the second measure, as results were
consistent across the two alternative measures.
We performed nonparametric between-group analyses
to determine if significant differences in screening
behavior existed between groups of patients sharing the
characteristics of age, race/ethnicity, previous history of
abnormal mammogram, family history of breast cancer,
level of household income, and level of education. Chisquared and Kruskal-Wallis tests, as well as logistic
regression, were used to assess the differences across
groups in the proportion of patients receiving screening
mammograms. Post-hoc pairwise comparison (Dunn’s
test) with Bonferroni correction determined significance
between groups, with a statistically significant threshold
of P<0.05. Additional chi-squared and Kruskal-Wallis
tests were performed to examine the distribution of patient
characteristics among clinicians to rule out potential
confounds based on differences in patient characteristics.
The study was approved by the University of Wisconsin
institutional review board for health sciences research.

RESULTS

SDM conversations between 54 women 40–49 years
of age and 11 different clinicians were analyzed. The
patients were predominantly white (51 of 54, (94.4%),
college-educated (39 of 54, 72.2%), and a slight
majority had annual household incomes greater than
$100,000 (28 of 53, 52.8%) (Table 1). The 11 clinicians
(10 female, 1 male) included 9 physicians and 2 nurse
practitioners, ranging in age from 37 to 63 years old and
in years of internal or family medicine practice from 9
to 36 (Table 2). Encounter transcriptions revealed no
significant differences between providers regarding the
characteristics of SDM, and all used the same online
decision aid.
Overall, 61% (33 of 54) of women had a mammogram.
Women with a history of a previous abnormal
mammogram or a family history of breast cancer were
significantly more likely to get a screening mammogram
based on the independent tests. However, these
differences became nonsignificant following application
of the Bonferroni correction, possibly due to the small
sample size. Almost 85% (11 of 13) of patients with a
history of an abnormal mammogram had a screening
mammogram during the follow-up period compared
with 46.4% (13 of 28) of patients without this history
(Figure 1). Similarly, 75% (15 of 20) of women with
a family history of breast cancer had a mammogram
compared with 51.6% (16 of 31) of patients without
family history of breast cancer.

Table 1. Patient Characteristics
Group

No. in
group

Percentage
screened

Group
differences

History of abnormal
mammogram

Yes
No

13
28

84.6%
46.4%

P=0.021 on χ²;
P=0.023 on K-W

0.138

Family history of breast
cancer

Yes
No

20
31

75.0%
51.6%

P=0.048 on χ²;
P=0.049 on K-W

0.294

40–44 years
45–49 years

31
22

54.8%
68.2%

P=0.328 on χ²;
P=0.332 on K-W

>0.999

Level of education

High school/GED
Some college
4-year college
More than 4-year college

4
11
21
18

50.0%
63.6%
71.4%
50.0%

P=0.549 on χ²;
P=0.557 on K-W

>0.999

Household income

<$40,000
$40,001–$75,000
$75,001–$100,000
>$100,000

4
13
8
28

25.0%
61.5%
62.5%
67.9%

P=0.630 on χ²;
P=0.640 on K-W

>0.999

Yes
No

7
46

85.7%
56.5%

P=0.141 on χ²;
P=0.145 on K-W

0.870

Characteristic

Patient age

Previous breast biopsy

P*

*with Bonferroni correction.
χ², chi-squared test; K-W, Kruskal-Wallis test.
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Table 2. Clinician Characteristics
Characteristic
Years in practice

Clinician ID

Groups

Degree,
Specialty

No. of
patients

Percentage
screened

Group
differences

Pairwise
comparison

<10
11–20
21–30
>30

–
–
–
–

7
22
15
10

57.1%
77.2%
26.6%
80.0%

P=0.010 on χ²;
P=0.010 on K-W

21–30 vs
11–20
21–30 vs
>30

0.013

1
2
3
4
5
6
7
8
9
10
11

NP
DO, Int Med
MD, Int Med
MD, Fam Med
MD, Fam Med
NP
DO, Fam Med
MD, Fam Med
MD, Fam Med
MD, Int Med
MD, Fam Med

6
3
1
7
3
7
3
2
6
7
9

100%
66.7%
100%
57.1%
66.7%
85.7%
33.3%
50.0%
0%
85.7%
44.4%

P=0.032 on χ²;
P=0.036 on K-W

Clinician 1 vs
Clinician 9

0.024

P*
0.048

*with Bonferroni correction.
χ², chi-squared test; Fam Med, family medicine; Int Med, internal medicine; K-W, Kruskal-Wallis test.

Of 7 patients seen by clinicians with <10 years of
experience, 4 (57%) received mammograms. This
compared to 77.2% (17 of 22), 26.6% (4 of 15), and 80%
(8 of 10) of patients visiting clinicians with 10–20, 21–
30, and >30 years of experience, respectively. Significant
differences were present between the group of patients
seen by clinicians with 21–30 years of experience as
compared to those of clinicians with 10–20 and >30 years
of experience (Figure 1).
To rule out alternative explanations that differences in
patient characteristics between clinicians account for
the differences in screening behavior across groups,
we examined the distribution of patient characteristics
among clinicians categorized either by family history of
breast cancer or patient history of abnormal mammogram.
No significant differences in patient characteristics were
found (P=0.695 per chi-squared and P=0.709 per KruskalWallis, and P=0.768 per chi-squared and P=0.782 on
Kruskal-Wallis, respectively).
As a robustness test, a logistic regression analysis was
run, with screening rate as the dependent variable and
years in practice as the independent variable. As there
were 4 ordered categories for years in practice, >30 years
in practice was defined as the baseline group. The overall
model was found to be significant (χ2: 11.622; P=.009;
log-likelihood ratio: 60.548). Additionally, the overall
variable of years in practice was found to be significant
(P=0.018). In terms of the years in practice categories,
the coefficient for 21–30 years in practice was significant
(odds ratio: 0.091; P=0.015); as the reference group was
Brief Report

clinicians with >30 years in practice, this coefficient
represents the difference between those with 21–30 vs
>30. These results were consistent with the chi-squared
and Kruskal-Wallis results.
Another logistic regression analysis that incorporated
years in practice as a continuous variable found no
significant results (χ2: 0.347; P=0.556; log-likelihood
ratio: 71.824), which lends support for grouping years in
practice to meaningfully differentiate between clinicians’
levels of experience.

DISCUSSION

SDM is by definition a patient-centered technique5 and
relies on patient beliefs and values. Our study of women
who all had structured SDM conversations with their
clinicians about breast cancer screening using the same
online patient decision aid demonstrated differences in
screening rates based on patient characteristics. However,
significant differences in screening rates also were
noted based on which clinician was seeing the patient.
Screening behaviors varied widely across individual
physicians, which raises the question of whether physician
preference/values, rather than patient preference/values,
might have been the driving force for whether or not the
patient ultimately underwent mammography. Research
has documented that clinician attitudes predict screening
rates of their patients, but such an outcome is antithetical
to the intended concept of SDM.6
Clinician attitudes may vary depending on the clinical
scenario and the evidence behind the intervention.7 Two
aah.org/jpcrr
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Figure 2. Screening
rates by patient
history of abnormal
mammogram,
patient’s family history
of breast cancer, and
clinician’s number of
years in practice.

studies that evaluated screening rates of primary care
clinicians in the Midwest found variable screening rates
by clinicians.2,3 Both studies also found that nonphysician
clinicians (ie, nurse practitioners or physician assistants)
tended to have higher rates of recommended screening
than their physician colleagues.2,3 The science behind
how primary care providers decide whether or not to
recommend screening is complicated and variable.
Both patient and provider variables can affect screening
decisions, as can individual perceptions of screening study
efficacy.8 Our study demonstrated variations in screening
rates within a context of a known SDM conversation
and use of a decision aid. The goal of decision aids is
to standardize SDM conversations and take clinician bias
out of the equation.9
Limitations of this study include a small sample size (54
women, 11 clinicians) and lack of diversity in the patient
sample, which was biased toward White, educated
women. However, all clinicians used a standardized
tool, minimizing practice variability, so we feel that our
results are still valid. It is possible that some women
preferentially choose clinicians who have similar
attitudes toward screening as themselves, which may
have introduced further bias.
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Our findings that women with history of an abnormal
mammogram and family history of breast cancer had
higher screening rates reinforce prior literature. The
overall study results raise important issues regarding
clinician training in shared decision-making that should
be a focus for future research.
Patient-Friendly Recap
• A clinical approach of “shared decision-making”
is recommended when discussing the pros and
cons of breast cancer screening with women in
their 40s.
• Authors investigated whether certain patient or
clinician features predict which patients will choose
to subsequently receive a mammogram.
• While women with a prior abnormal mammogram
result or family history of breast cancer more
frequently opted for screening, rates also varied
widely between clinicians, indicating clinician
attitudes may have overly impacted the decisionmaking conversation.
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